following

State of Oregon Invests in Meriwether Group Capitals Hero Fund Following Third-Party Review

With three years of audited returns of 11%, the private credit platform gains institutional backing to support next-stage growthPORTLAND, Ore.--(BUSINESS…

2 days ago

GIGABYTE Announces its AI PCs – GIGABYTE AERO X16 and GIGABYTE GAMING A16 Now Officially Available

TAIPEI, July 16, 2025 /PRNewswire/ -- Following the successful debut of the AORUS MASTER 18 and 16, GIGABYTE, the world's leading…

5 days ago

IOC documentary series starring Simone Biles nominated for Primetime Emmy Award

16 July 2025 - The acclaimed Netflix documentary series following seven-time Olympic champion Simone Biles on her remarkable journey to the…

1 week ago

Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure

Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /PRNewswire/ -- Berlin…

1 week ago

WSPN Website Expands to Full Platform, Showcasing Enterprise-Ready Stablecoin Infrastructure

TORTOLA, British Virgin Islands, July 9, 2025 /PRNewswire/ -- Following its homepage redesign in May, Worldwide Stablecoin Payment Network (WSPN, collectively referring…

2 weeks ago

Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025

SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

2 weeks ago

Red FM Announces Season 3 of the Quiz India Movement – The Ultimate T20 League Quiz Challenge

Indias leading private radio and entertainment network, Red FM, announced season 3 of the Quiz India Movement, a celebration of…

3 weeks ago

Ingram Micro Issues Statement Regarding Cybersecurity Incident

IRVINE, Calif.--(BUSINESS WIRE)--Ingram Micro Holding Corporation (NYSE: INGM) (“Ingram Micro” or the “Company”) today issued the following statement with respect…

3 weeks ago

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

July 04, 2025 03:00 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma…

3 weeks ago